Safety, ethics and regulations

This invaluable resource discusses the saftey, ethics, and regulations of developing stem cell clinical applications. Each chapter is contributed by a preeminent scientist in the field and covers such topics as clinical safety of stem cell gene therapy, the patentability of hESC technologies, intern...

Full description

Saved in:
Bibliographic Details
Other Authors: Pham, Phuc Van. (Editor), Rosemann, Achim. (Editor)
Format: eBook
Language: English
Published: Springer Verlag 2017.
Series: Stem cells in clinical applications.
Subjects:
Stem cells > Transplantation > Moral and ethical aspects.
Stem cells > Transplantation > Safety measures.
elektronické knihy
electronic books
ISBN: 9783319591650
9783319591643
Physical Description: 1 online resource

Cover

Table of contents

LEADER 05571cam a2200481M 4500
001 97459
003 CZ-ZlUTB
005 20240914110605.0
006 m o d
007 cr |n|||||||||
008 170815s2017 xx o 000 0 eng d
040 |a YDX  |b eng  |e pn  |c YDX  |d N$T  |d EBLCP  |d GW5XE  |d OCLCO  |d N$T  |d DKU  |d UAB  |d AZU  |d MERER  |d OCLCQ  |d ESU  |d IOG  |d COO  |d U3W  |d CAUOI  |d OCLCQ  |d KSU  |d OCLCQ  |d VT2  |d WYU  |d OCLCQ  |d UKAHL  |d OCLCQ  |d ADU  |d OCLCQ 
020 |a 9783319591650  |q (electronic bk.) 
020 |z 9783319591643 
024 7 |a 10.1007/978-3-319-59165-0  |2 doi 
035 |a (OCoLC)1001271928  |z (OCoLC)1001313019  |z (OCoLC)1005010623  |z (OCoLC)1011904265  |z (OCoLC)1048115912  |z (OCoLC)1066461919  |z (OCoLC)1113412105 
245 0 0 |a Safety, ethics and regulations /  |c Phuc Van Pham, Achim Rosemann, editors. 
260 |b Springer Verlag  |c 2017. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a počítač  |b c  |2 rdamedia 
338 |a online zdroj  |b cr  |2 rdacarrier 
490 1 |a Stem cells in clinical applications 
505 0 |a Preface; About the Editors; Contents; Contributors; Part I: Safety; Chapter 1: The Safety of Allogeneic Stem Cell Transplantation; 1.1 Introduction; 1.2 Stem Cell Sources; 1.2.1 Bone Marrow; 1.2.2 Peripheral Blood Stem Cells; 1.2.3 Umbilical Cord Blood; 1.3 Donor Selection and Testing; 1.3.1 HLA Restrictions; 1.3.2 Related Donor; 1.3.3 Unrelated Donor; 1.3.4 Cord Blood; 1.4 Reported Microbiological Transmissions; 1.4.1 Transmission of Human Immunodeficiency Virus Type 1 (HIV-1); 1.4.1.1 Prevention of HIV Transmission by a Viremic Donor; 1.4.2 Transmission of Hepatitis B Virus (HBV). 
505 8 |a 1.4.2.1 How to Proceed with Anti-HBc-Positive Donors?1.4.2.2 Prevention of HBV Infection in Case of HBV Viremic Donors; 1.4.3 Transmission of Hepatitis C Virus (HCV); 1.4.3.1 Prevention of HCV Transmission; 1.4.4 Transmission of HTLV-I + II; 1.4.5 Cytomegalic Virus (CMV) in CMV-Negative Recipients; 1.4.6 Possible Risks from Donors with Epstein-Barr Virus (EBV); 1.4.7 Transmission of Treponema pallidum; 1.4.8 Commensal Bacteria; 1.4.9 Other Pathogens; 1.5 Transfusion-Related Complications; 1.5.1 Transfusion-Related Acute Lung Injury (TRALI); 1.5.2 Hemolytic Transfusion Reaction (HTR). 
505 8 |a 1.6 Risk of Transmission of Donor-Derived Noninfectious Diseases1.6.1 Possible Long-Time Effects; 1.6.2 Donor-Derived Malignancies; 1.7 Conclusion; References; Chapter 2: Induced Pluripotent Stem Cell Therapy and Safety Concerns in Age-Related Chronic Neurodegenerative Diseases; 2.1 Overview of Age-Related Chronic Neurodegenerative Diseases; 2.1.1 Alzheimer's Disease; 2.1.2 Parkinson's Disease; 2.2 Induced Pluripotent Stem Cells Technology; 2.2.1 Reprogramming Methods; 2.2.1.1 Viral Vector-Based Methods; 2.2.1.2 Naked DNA-Based Methods; 2.2.1.3 Non-DNA-Based Methods; 2.3 Applications of iPSCs. 
505 8 |a 2.3.1 Disease Modeling2.3.2 Drug Screening and Testing; 2.3.3 Cell Replacement Therapy; 2.4 Future Directions: Challenges and Advancements; 2.4.1 Limitations in iPSC Generation and Potential Solutions; 2.4.1.1 Integration into Genome; 2.4.1.2 Epigenetic Memory; 2.4.1.3 Differentiation and Purity; 2.4.1.4 Control Groups for Research; 2.4.2 Safety Concerns for Clinical Grade iPSCs; 2.4.2.1 Tumorigenicity, Immunogenicity, and Genomic Instability; 2.4.2.2 Biobanking; 2.4.2.3 Clearance of Animal Products; 2.4.3 Recent Biological and Biotechnological Advancements. 
505 8 |a 2.4.3.1 Alternative Strategies for Reprogramming2.4.3.2 Three-Dimensional (3D) and Organoid Cultures; 2.4.3.3 Biotechnological Strategies; Biomaterials; Bioprinting; 2.5 Conclusion; References; Chapter 3: Clinical Safety and Applications of Stem Cell Gene Therapy; 3.1 Introduction; 3.2 Applications; 3.3 Safety; 3.3.1 Proof of Concept; 3.3.2 The Preclinical Testing Program; 3.3.3 Suicide Genes; 3.4 Efficacy; 3.4.1 Promoter Selection; 3.4.2 Transduction Efficiency; 3.4.3 Engraftment Efficiency; 3.5 Gene Therapy Procedures; 3.6 Way Forward; 3.7 Conclusion; References. 
506 |a Plný text je dostupný pouze z IP adres počítačů Univerzity Tomáše Bati ve Zlíně nebo vzdáleným přístupem pro zaměstnance a studenty 
520 |a This invaluable resource discusses the saftey, ethics, and regulations of developing stem cell clinical applications. Each chapter is contributed by a preeminent scientist in the field and covers such topics as clinical safety of stem cell gene therapy, the patentability of hESC technologies, international guidelines, challenges to international stem cell clinical trials, worldwide regulations including in emerging markets like China and Taiwan. Saftey, Ethics, and Regulations and the other books in the Stem Cells in Clinical Applications series will be invaluable to scientists, researchers, advanced students and clinicians working in stem cells, regenerative medicine or tissue engineering. 
590 |a SpringerLink  |b Springer Complete eBooks 
650 0 |a Stem cells  |x Transplantation  |x Moral and ethical aspects. 
650 0 |a Stem cells  |x Transplantation  |x Safety measures. 
655 7 |a elektronické knihy  |7 fd186907  |2 czenas 
655 9 |a electronic books  |2 eczenas 
700 1 |a Pham, Phuc Van.  |4 edt 
700 1 |a Rosemann, Achim.  |4 edt 
776 0 8 |i Print version:  |z 9783319591643  |z 3319591649  |w (OCoLC)985082620 
830 0 |a Stem cells in clinical applications. 
856 4 0 |u https://proxy.k.utb.cz/login?url=https://link.springer.com/10.1007/978-3-319-59165-0  |y Plný text 
992 |c NTK-SpringerBLS 
999 |c 97459  |d 97459 
993 |x NEPOSILAT  |y EIZ 

Similar Items